MANY MINDEDBrain Tumor Test Cuts UK Diagnosis Time to Two Hours During Surgery
NHS England is piloting a genomic test developed by the University of Nottingham's Brain Tumour Research Centre of Excellence in five specialist hospitals: Nottingham University Hospitals, University Hospitals Birmingham, Great Ormond Street, King's College Hospital, and Newcastle Hospitals. The test uses Oxford Nanopore technology to sequence DNA during surgery, reducing diagnosis time from up to eight weeks to two hours for primary brain tumors. This significant reduction applies to the period from symptom onset to final confirmation, not surgical intervention itself.
The test targets primary brain tumors—the leading cause of death for children and adults under 40 in the UK—by enabling rapid identification during surgery. NHS England expects to expand the pilot to Bristol, Oxford, Leeds, and Manchester after the current phase. Medical director Prof Frankie Swords described its potential to 'completely transform' brain tumor diagnosis.
This development moves abundance for the critical need of timely cancer treatment by preventing fatal deterioration in patients with aggressive tumors who have minimal time before clinical decline. Faster diagnosis during surgery directly addresses the life-threatening urgency of primary brain tumors, a group where delays often mean irreversible harm.
Next steps include scaling the pilot to additional NHS centers. Caveats: the program remains limited to five sites as of 2026; the time reduction excludes surgical procedures; and the test is specifically for primary brain tumors, not other tumor types.
Source: Guardian